Prognostic role of prostate-specific antigen and prostate volume for the risk of invasive therapy in patients with benign prostatic hyperplasia initially managed with alpha1-blockers and watchful waiting.

Source:http://linkedlifedata.com/resource/pubmed/id/15708042

Download in:

View as

General Info

PMID
15708042